| # | Drug | Count |
|---|---|---|
| 0 | RANIBIZUMAB | 7 |
| 1 | ALBENDAZOLE | 1 |
| 2 | ALENDRONATE SODIUM | 1 |
| 3 | CEFUROXIME | 1 |
| 4 | FINGOLIMOD HCL | 1 |
| 5 | INSULIN | 1 |
| 6 | LENALIDOMIDE | 1 |
| 7 | PEMBROLIZUMAB | 1 |
| 8 | QUININE | 1 |
| 9 | SILDENAFIL CITRATE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ALBENDAZOLE | 1 | 0.0005 |
| 1 | RANIBIZUMAB | 7 | 0.0003 |
| 2 | QUININE | 1 | 0.0001 |
| 3 | CEFUROXIME | 1 | 0.0001 |
| 4 | VIGABATRIN | 1 | 0.0001 |
| 5 | TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05% | 1 | 0.0000 |
| 6 | TRIAMCINOLONE ACETONIDE | 1 | 0.0000 |
| 7 | FINGOLIMOD HCL | 1 | 0.0000 |
| 8 | ALENDRONATE SODIUM | 1 | 0.0000 |
| 9 | PEMBROLIZUMAB | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 7 |
| 1 | Anthelmintic [EPC] | 1 |
| 2 | Anti-epileptic Agent [EPC] | 1 |
| 3 | Corticosteroid [EPC] | 1 |
| 4 | Insulin Analog [EPC] | 1 |
| 5 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 |
| 6 | Thalidomide Analog [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anthelmintic [EPC] | 1 | 0.0003 |
| 1 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 7 | 0.0000 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |
| 3 | Anti-epileptic Agent [EPC] | 1 | 0.0000 |
| 4 | Insulin Analog [EPC] | 1 | 0.0000 |
| 5 | Thalidomide Analog [EPC] | 1 | 0.0000 |
| 6 | Corticosteroid [EPC] | 1 | 0.0000 |